Lymphotropic Pattern of Prostate-specific Membrane Antigen-detected Metastases Among Biochemically Recurrent Radical Prostatectomy Patients with Cribriform Disease

被引:3
作者
Bernardino, Rui [1 ,8 ]
Sayyid, Rashid K. [1 ]
Al-Daqqaq, Zizo [2 ]
Tiwari, Raj [1 ]
Cockburn, Jessica [1 ]
Vijayakanthan, Shagana [3 ]
Qaoud, Yazan [1 ]
Berjaoui, Mohamad Baker [1 ]
Metser, Ur [4 ]
Berlin, Alejandro [5 ,6 ]
van der Kwast, Theodorus [7 ]
Fleshner, Neil E. [1 ]
机构
[1] Univ Toronto, Princess Margaret Canc Ctr, Dept Surg Oncol, Div Urol, Toronto, ON, Canada
[2] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[3] Univ Galway, Sch Med, Galway, Ireland
[4] Univ Hlth Network, Joint Dept Med Imaging, Toronto, ON, Canada
[5] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
[6] Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada
[7] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[8] Univ Toronto, Princess Margaret Canc Ctr, 700 Univ Ave, Toronto, ON M5G 1Z5, Canada
关键词
Prostatic neoplasms; Positron-emission tomography; Lymph nodes; INTRADUCTAL CARCINOMA; CANCER; ASSOCIATION; DEFINITION; SURVIVAL; IMPACT; SITE;
D O I
10.1016/j.euf.2023.05.005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Cribriform morphology portends worse oncologic outcomes, and has unique cellular intrinsic pathway alterations and tumor microenvironments that may impact metastatic spread patterns.Objective: To determine whether the presence of cribriform morphology in prostatectomy specimens of patients with biochemical recurrence after radical prostatectomy (RP) is associated with the presence of metastasis on prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and a distinct pattern of spread.Design, setting, and participants: A cross-sectional analysis was conducted of all prostate cancer patients with biochemical recurrence after RP undergoing 18F-DCFPyL-PET/CT between December 2018 and February 2021 at the Princess Margaret Cancer Centre.Outcome measurements and statistical analysis: Outcomes were presence of any metastasis in the overall cohort and lymphatic versus bone/visceral metastases among patients with metastatic disease. The associations between the presence of intraductal (IDC) and/or invasive cribriform (ICC) carcinoma on the RP specimen and study outcomes were evaluated using logistic regression analyses. Results and limitations: The cohort included 176 patients. IDC and ICC were observed in 77 (43.8%) and 80 (45.5%) RP specimens, respectively. The median time from RP to PSMA-PET/CT was 5.0 yr. The median serum prostate-specific antigen level at PSMAPET/CT was 1.12 ng/ml. Overall, metastasis was observed in 77 patients, of whom 58 were had lymphatic-only metastasis. On a multivariable analysis, presence of IDC on RP was associated with increased odds of overall metastasis (odds ratio [OR]: 2.17; 95% confidence interval [CI]: 1.07-4.45; p = 0.033). Presence of ICC on RP was associated with significantly increased odds of lymphatic versus bone/visceral metastases (OR: 3.13; 95% CI: 1.09-21.7; p = 0.004).Conclusions: Presence of cribriform morphology on RP specimens of patients with bio-chemical failure after RP is associated with increased odds of PSMA-PET/CT-detected metastases with a lymphatic predominant pattern of spread. These findings have impli-cations for the design and evaluation of post-RP salvage therapies.Patient summary: We found that microscopic cribriform appearance correlates with dis-ease spread on imaging in prostate cancer patients with recurrence and has a predilec-tion for spread to lymph nodes, as opposed to bone or visceral organs. (c) 2023 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1016 / 1023
页数:8
相关论文
共 29 条
[1]   Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making [J].
Abida, Wassim ;
Armenia, Joshua ;
Gopalan, Anuradha ;
Brennan, Ryan ;
Walsh, Michael ;
Barron, David ;
Danila, Daniel ;
Rathkopf, Dana ;
Morris, Michael ;
Slovin, Susan ;
McLaughlin, Brigit ;
Curtis, Kristen ;
Hyman, David M. ;
Durack, Jeremy C. ;
Solomon, Stephen B. ;
Arcila, Maria E. ;
Zehir, Ahmet ;
Syed, Aijazuddin ;
Gao, Jianjiong ;
Chakravarty, Debyani ;
Vargas, Hebert Alberto ;
Robson, Mark E. ;
Vijai, Joseph ;
Offit, Kenneth ;
Donoghue, Mark T. A. ;
Abeshouse, Adam A. ;
Kundra, Ritika ;
Heins, Zachary J. ;
Penson, Alexander V. ;
Harris, Christopher ;
Taylor, Barry S. ;
Ladanyi, Marc ;
Mandelker, Diana ;
Zhang, Liying ;
Reuter, Victor E. ;
Kantoff, Philip W. ;
Solit, David B. ;
Berger, Michael F. ;
Sawyers, Charles L. ;
Schultz, Nikolaus ;
Scher, Howard I. .
JCO PRECISION ONCOLOGY, 2017, 1 :1-26
[2]   Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer [J].
Annala, Matti ;
Vandekerkhove, Gillian ;
Khalaf, Daniel ;
Taavitsainen, Sinja ;
Beja, Kevin ;
Warner, Evan W. ;
Sunderland, Katherine ;
Kollmannsberger, Christian ;
Eigl, Bernhard J. ;
Finch, Daygen ;
Oja, Conrad D. ;
Vergidis, Joanna ;
Zulfiqar, Muhammad ;
Azad, Arun A. ;
Nykter, Matti ;
Gleave, Martin E. ;
Wyatt, Alexander W. ;
Chi, Kim N. .
CANCER DISCOVERY, 2018, 8 (04) :444-457
[3]   Revisiting Prostate Cancer Recurrence with PSMA PET: Atlas of Typical and Atypical Patterns of Spread [J].
Barbosa, Felipe G. ;
Queiroz, Marcelo A. ;
Nunes, Rafael F. ;
Viana, Publio C. C. ;
Marin, Jose Flavio G. ;
Cerri, Giovanni G. ;
Buchpiguel, Carlos A. .
RADIOGRAPHICS, 2019, 39 (01) :186-212
[4]   Cribriform pattern disease over-represented in pelvic lymph node metastases identified on 68GA PSMA-PET/CT [J].
Bolton, Damien ;
Hong, Anne ;
Papa, Nathan ;
Perera, Marlon ;
Kelly, Brian ;
Duncan, Catriona ;
Clouston, David ;
Lawrentschuk, Nathan .
BJUI COMPASS, 2022, 3 (05) :371-376
[5]   Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations [J].
Bottcher, Rene ;
Kweldam, Charlotte F. ;
Livingstone, Julie ;
Lalonde, Emilie ;
Yamaguchi, Takafumi N. ;
Huang, Vincent ;
Yousif, Fouad ;
Fraser, Michael ;
Bristow, Robert G. ;
van der Kwast, Theodorus ;
Boutros, Paul C. ;
Jenster, Guido ;
van Leenders, Geert J. L. H. .
BMC CANCER, 2018, 18
[6]  
Branca G, 2017, ONCOL REV, V11, DOI 10.4081/oncol.2017.317
[7]   The evolving Gleason grading system [J].
Chen, Ni ;
Zhou, Qiao .
CHINESE JOURNAL OF CANCER RESEARCH, 2016, 28 (01) :58-64
[8]   Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer update panel report and recommendations for a standard in the reporting of surgical outcomes [J].
Cookson, Michael S. ;
Aus, Gunnar ;
Burnett, Arthur L. ;
Canby-Hagino, Edith D. ;
D'Amico, Anthony V. ;
Dmochowski, Roger R. ;
Eton, David T. ;
Forman, Jeffrey D. ;
Goldenberg, S. Larry ;
Hernandez, Javier ;
Higano, Celestia S. ;
Kraus, Stephen R. ;
Moul, Judd W. ;
Tangen, Catherine ;
Thrasher, J. Brantley ;
Thompson, Ian .
JOURNAL OF UROLOGY, 2007, 177 (02) :540-545
[9]   Impact of 18F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer [J].
Dias, Adriano Basso ;
Finelli, Antonio ;
Bauman, Glenn ;
Veit-Haibach, Patrick ;
Berlin, Alejandro ;
Ortega, Claudia ;
Avery, Lisa ;
Metser, Ur .
RADIOLOGY, 2022, 304 (03) :600-608
[10]   Architectural Heterogeneity and Cribriform Pattern Predict Adverse Clinical Outcome for Gleason Grade 4 Prostatic Adenocarcinoma [J].
Dong, Fei ;
Yang, Ping ;
Wang, Chaofu ;
Wu, Shulin ;
Xiao, Yu ;
McDougal, W. Scott ;
Young, Robert H. ;
Wu, Chin-Lee .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (12) :1855-1861